Company description
Juliet Barker, MBBS (Hons), FRACP, is an Australian trained hematologist. Having been an Attending Member and Physician at Memorial Sloan Kettering Cancer Center (MSKCC) and the Director of the MSKCC Cord Blood (CB) Transplantation Program, Dr. Barker has been recruited to Weill Cornell Medicine and NewYork-Presbyterian Hospital as the Director of the Bone Marrow Transplant and Cellular Therapy Program.Over the last 25 years, Dr. Barker has worked to expand transplant access to minority patients with hematologic malignancies and has demonstrated the ability of cord blood transplantation to provide curative therapy for such populations without suitable adult donors. Dr. Barker’s work in this area has been internationally recognized and she has published extensively concerning novel strategies to optimize access to donor transplants and cord blood transplant outcomes. Additionally, she has a special focus on optimizing complex health care delivery such as hematopoietic stem cell transplantation in under-served populations. Dr. Barker has advised the National Marrow Donor Program (NMDP) and is a member of the Advisory Council on Blood Stem Cell Transplantation to the Health Resources and Services Administration of the U.S. government. She has served on the American Society for Transplantation and Cellular Therapy (ASTCT) Board and led the national ASTCT Cord Blood Special Interest Group. Having previously served as Associate Vice Chair, Faculty Development, in the Department of Medicine at MSKCC, Dr. Barkeralso has a keen interest in academic mentorship.
